{
 "cells": [
  {
   "cell_type": "code",
   "execution_count": 1,
   "metadata": {},
   "outputs": [],
   "source": [
    "import sys\n",
    "sys.path.append('../src')\n",
    "\n",
    "XML_PATH = '../data/drugbank_partial.xml'"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "# Task #1"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 2,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>drugbank_id</th>\n",
       "      <th>name</th>\n",
       "      <th>type</th>\n",
       "      <th>description</th>\n",
       "      <th>dosage_form</th>\n",
       "      <th>indication</th>\n",
       "      <th>mechanism_of_action</th>\n",
       "      <th>food_interactions</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>DB00001</td>\n",
       "      <td>Lepirudin</td>\n",
       "      <td>biotech</td>\n",
       "      <td>Lepirudin is a recombinant hirudin formed by 6...</td>\n",
       "      <td>None</td>\n",
       "      <td>Lepirudin is indicated for anticoagulation in ...</td>\n",
       "      <td>Lepirudin is a direct thrombin inhibitor used ...</td>\n",
       "      <td>Avoid herbs and supplements with anticoagulant...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1</th>\n",
       "      <td>DB00002</td>\n",
       "      <td>Cetuximab</td>\n",
       "      <td>biotech</td>\n",
       "      <td>Cetuximab is a recombinant chimeric human/mous...</td>\n",
       "      <td>None</td>\n",
       "      <td>Cetuximab indicated for the treatment of local...</td>\n",
       "      <td>The epidermal growth factor receptor (EGFR) is...</td>\n",
       "      <td></td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2</th>\n",
       "      <td>DB00003</td>\n",
       "      <td>Dornase alfa</td>\n",
       "      <td>biotech</td>\n",
       "      <td>Dornase alfa is a biosynthetic form of human d...</td>\n",
       "      <td>None</td>\n",
       "      <td>Used as adjunct therapy in the treatment of cy...</td>\n",
       "      <td>Dornase alfa is a biosynthetic form of human D...</td>\n",
       "      <td></td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3</th>\n",
       "      <td>DB00004</td>\n",
       "      <td>Denileukin diftitox</td>\n",
       "      <td>biotech</td>\n",
       "      <td>A recombinant DNA-derived cytotoxic protein co...</td>\n",
       "      <td>None</td>\n",
       "      <td>For treatment of cutaneous T-cell lymphoma</td>\n",
       "      <td>Denileukin diftitox binds to the high-affinity...</td>\n",
       "      <td></td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>4</th>\n",
       "      <td>DB00005</td>\n",
       "      <td>Etanercept</td>\n",
       "      <td>biotech</td>\n",
       "      <td>Dimeric fusion protein consisting of the extra...</td>\n",
       "      <td>None</td>\n",
       "      <td>Etanercept is indicated for the treatment of m...</td>\n",
       "      <td>There are two distinct receptors for TNF (TNFR...</td>\n",
       "      <td></td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>5</th>\n",
       "      <td>DB00006</td>\n",
       "      <td>Bivalirudin</td>\n",
       "      <td>small molecule</td>\n",
       "      <td>Bivalirudin is a synthetic 20 residue peptide ...</td>\n",
       "      <td>None</td>\n",
       "      <td>For treatment of heparin-induced thrombocytope...</td>\n",
       "      <td>Inhibits the action of thrombin by binding bot...</td>\n",
       "      <td>Avoid echinacea.; Avoid herbs and supplements ...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>6</th>\n",
       "      <td>DB00007</td>\n",
       "      <td>Leuprolide</td>\n",
       "      <td>small molecule</td>\n",
       "      <td>Leuprolide is a synthetic 9-residue peptide an...</td>\n",
       "      <td>None</td>\n",
       "      <td>Leuprolide is indicated for the treatment of a...</td>\n",
       "      <td>Gonadotropin-releasing hormone (GnRH) is a nat...</td>\n",
       "      <td></td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>7</th>\n",
       "      <td>DB00008</td>\n",
       "      <td>Peginterferon alfa-2a</td>\n",
       "      <td>biotech</td>\n",
       "      <td>Peginterferon alfa-2a is a form of recombinant...</td>\n",
       "      <td>None</td>\n",
       "      <td>Peginterferon alfa-2a is indicated for the tre...</td>\n",
       "      <td>Peginterferon alfa-2a is derived from recombin...</td>\n",
       "      <td>Drink plenty of fluids.</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>8</th>\n",
       "      <td>DB00009</td>\n",
       "      <td>Alteplase</td>\n",
       "      <td>biotech</td>\n",
       "      <td>Alteplase is a recombinant tissue plasminogen ...</td>\n",
       "      <td>None</td>\n",
       "      <td>Alteplase is indicated for the treatment of ac...</td>\n",
       "      <td>Alteplase is a recombinant tissue plasminogen ...</td>\n",
       "      <td>Avoid herbs and supplements with anticoagulant...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>9</th>\n",
       "      <td>DB00010</td>\n",
       "      <td>Sermorelin</td>\n",
       "      <td>biotech</td>\n",
       "      <td>Sermorelin acetate is the acetate salt of an a...</td>\n",
       "      <td>None</td>\n",
       "      <td>For the treatment of dwarfism, prevention of H...</td>\n",
       "      <td>Sermorelin binds to the growth hormone releasi...</td>\n",
       "      <td></td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "</div>"
      ],
      "text/plain": [
       "  drugbank_id                   name            type  \\\n",
       "0     DB00001              Lepirudin         biotech   \n",
       "1     DB00002              Cetuximab         biotech   \n",
       "2     DB00003           Dornase alfa         biotech   \n",
       "3     DB00004    Denileukin diftitox         biotech   \n",
       "4     DB00005             Etanercept         biotech   \n",
       "5     DB00006            Bivalirudin  small molecule   \n",
       "6     DB00007             Leuprolide  small molecule   \n",
       "7     DB00008  Peginterferon alfa-2a         biotech   \n",
       "8     DB00009              Alteplase         biotech   \n",
       "9     DB00010             Sermorelin         biotech   \n",
       "\n",
       "                                         description dosage_form  \\\n",
       "0  Lepirudin is a recombinant hirudin formed by 6...        None   \n",
       "1  Cetuximab is a recombinant chimeric human/mous...        None   \n",
       "2  Dornase alfa is a biosynthetic form of human d...        None   \n",
       "3  A recombinant DNA-derived cytotoxic protein co...        None   \n",
       "4  Dimeric fusion protein consisting of the extra...        None   \n",
       "5  Bivalirudin is a synthetic 20 residue peptide ...        None   \n",
       "6  Leuprolide is a synthetic 9-residue peptide an...        None   \n",
       "7  Peginterferon alfa-2a is a form of recombinant...        None   \n",
       "8  Alteplase is a recombinant tissue plasminogen ...        None   \n",
       "9  Sermorelin acetate is the acetate salt of an a...        None   \n",
       "\n",
       "                                          indication  \\\n",
       "0  Lepirudin is indicated for anticoagulation in ...   \n",
       "1  Cetuximab indicated for the treatment of local...   \n",
       "2  Used as adjunct therapy in the treatment of cy...   \n",
       "3         For treatment of cutaneous T-cell lymphoma   \n",
       "4  Etanercept is indicated for the treatment of m...   \n",
       "5  For treatment of heparin-induced thrombocytope...   \n",
       "6  Leuprolide is indicated for the treatment of a...   \n",
       "7  Peginterferon alfa-2a is indicated for the tre...   \n",
       "8  Alteplase is indicated for the treatment of ac...   \n",
       "9  For the treatment of dwarfism, prevention of H...   \n",
       "\n",
       "                                 mechanism_of_action  \\\n",
       "0  Lepirudin is a direct thrombin inhibitor used ...   \n",
       "1  The epidermal growth factor receptor (EGFR) is...   \n",
       "2  Dornase alfa is a biosynthetic form of human D...   \n",
       "3  Denileukin diftitox binds to the high-affinity...   \n",
       "4  There are two distinct receptors for TNF (TNFR...   \n",
       "5  Inhibits the action of thrombin by binding bot...   \n",
       "6  Gonadotropin-releasing hormone (GnRH) is a nat...   \n",
       "7  Peginterferon alfa-2a is derived from recombin...   \n",
       "8  Alteplase is a recombinant tissue plasminogen ...   \n",
       "9  Sermorelin binds to the growth hormone releasi...   \n",
       "\n",
       "                                   food_interactions  \n",
       "0  Avoid herbs and supplements with anticoagulant...  \n",
       "1                                                     \n",
       "2                                                     \n",
       "3                                                     \n",
       "4                                                     \n",
       "5  Avoid echinacea.; Avoid herbs and supplements ...  \n",
       "6                                                     \n",
       "7                            Drink plenty of fluids.  \n",
       "8  Avoid herbs and supplements with anticoagulant...  \n",
       "9                                                     "
      ]
     },
     "execution_count": 2,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "from transformations import build_drugs_dataframe\n",
    "\n",
    "df_drugs = build_drugs_dataframe(XML_PATH)\n",
    "df_drugs.head(10)\n",
    "\n",
    "# TODO: dosage_form"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "# Task #2"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 3,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>drugbank_id</th>\n",
       "      <th>synonym</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>DB00001</td>\n",
       "      <td>[Leu1, Thr2]-63-desulfohirudin</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1</th>\n",
       "      <td>DB00001</td>\n",
       "      <td>Desulfatohirudin</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2</th>\n",
       "      <td>DB00001</td>\n",
       "      <td>Hirudin variant-1</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3</th>\n",
       "      <td>DB00001</td>\n",
       "      <td>Lepirudin</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>4</th>\n",
       "      <td>DB00001</td>\n",
       "      <td>Lepirudin recombinant</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>5</th>\n",
       "      <td>DB00001</td>\n",
       "      <td>R-hirudin</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>6</th>\n",
       "      <td>DB00002</td>\n",
       "      <td>Cetuximab</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>7</th>\n",
       "      <td>DB00002</td>\n",
       "      <td>Cétuximab</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>8</th>\n",
       "      <td>DB00002</td>\n",
       "      <td>Cetuximabum</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>9</th>\n",
       "      <td>DB00003</td>\n",
       "      <td>Deoxyribonuclease (human clone 18-1 protein mo...</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "</div>"
      ],
      "text/plain": [
       "  drugbank_id                                            synonym\n",
       "0     DB00001                     [Leu1, Thr2]-63-desulfohirudin\n",
       "1     DB00001                                   Desulfatohirudin\n",
       "2     DB00001                                  Hirudin variant-1\n",
       "3     DB00001                                          Lepirudin\n",
       "4     DB00001                              Lepirudin recombinant\n",
       "5     DB00001                                          R-hirudin\n",
       "6     DB00002                                          Cetuximab\n",
       "7     DB00002                                          Cétuximab\n",
       "8     DB00002                                        Cetuximabum\n",
       "9     DB00003  Deoxyribonuclease (human clone 18-1 protein mo..."
      ]
     },
     "execution_count": 3,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "from transformations import build_synonyms_dataframe\n",
    "\n",
    "df_synonyms = build_synonyms_dataframe(XML_PATH)\n",
    "df_synonyms.head(10)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 4,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "image/png": "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",
      "text/plain": [
       "<Figure size 640x480 with 1 Axes>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    }
   ],
   "source": [
    "from visualizations import draw_synonym_graph\n",
    "\n",
    "example_drug_id = df_synonyms[\"drugbank_id\"].unique()[0]\n",
    "\n",
    "draw_synonym_graph(example_drug_id, df_synonyms)"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "# Task #3"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 5,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>drugbank_id</th>\n",
       "      <th>product_name</th>\n",
       "      <th>labeller</th>\n",
       "      <th>ndc_product_code</th>\n",
       "      <th>dosage_form</th>\n",
       "      <th>route</th>\n",
       "      <th>strength</th>\n",
       "      <th>country</th>\n",
       "      <th>source</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>DB00001</td>\n",
       "      <td>Refludan</td>\n",
       "      <td>Bayer</td>\n",
       "      <td>50419-150</td>\n",
       "      <td>Powder</td>\n",
       "      <td>Intravenous</td>\n",
       "      <td>50 mg/1mL</td>\n",
       "      <td>US</td>\n",
       "      <td>FDA NDC</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1</th>\n",
       "      <td>DB00001</td>\n",
       "      <td>Refludan</td>\n",
       "      <td>Bayer</td>\n",
       "      <td></td>\n",
       "      <td>Powder, for solution</td>\n",
       "      <td>Intravenous</td>\n",
       "      <td>50 mg / vial</td>\n",
       "      <td>Canada</td>\n",
       "      <td>DPD</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2</th>\n",
       "      <td>DB00001</td>\n",
       "      <td>Refludan</td>\n",
       "      <td>Celgene Europe Limited</td>\n",
       "      <td></td>\n",
       "      <td>Injection, solution, concentrate</td>\n",
       "      <td>Intravenous</td>\n",
       "      <td>50 mg</td>\n",
       "      <td>EU</td>\n",
       "      <td>EMA</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3</th>\n",
       "      <td>DB00001</td>\n",
       "      <td>Refludan</td>\n",
       "      <td>Celgene Europe Limited</td>\n",
       "      <td></td>\n",
       "      <td>Injection, solution, concentrate</td>\n",
       "      <td>Intravenous</td>\n",
       "      <td>50 mg</td>\n",
       "      <td>EU</td>\n",
       "      <td>EMA</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>4</th>\n",
       "      <td>DB00001</td>\n",
       "      <td>Refludan</td>\n",
       "      <td>Celgene Europe Limited</td>\n",
       "      <td></td>\n",
       "      <td>Injection, solution, concentrate</td>\n",
       "      <td>Intravenous</td>\n",
       "      <td>20 mg</td>\n",
       "      <td>EU</td>\n",
       "      <td>EMA</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>5</th>\n",
       "      <td>DB00001</td>\n",
       "      <td>Refludan</td>\n",
       "      <td>Celgene Europe Limited</td>\n",
       "      <td></td>\n",
       "      <td>Injection, solution, concentrate</td>\n",
       "      <td>Intravenous</td>\n",
       "      <td>20 mg</td>\n",
       "      <td>EU</td>\n",
       "      <td>EMA</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>6</th>\n",
       "      <td>DB00002</td>\n",
       "      <td>Erbitux</td>\n",
       "      <td>ImClone LLC</td>\n",
       "      <td>66733-948</td>\n",
       "      <td>Solution</td>\n",
       "      <td>Intravenous</td>\n",
       "      <td>2 mg/1mL</td>\n",
       "      <td>US</td>\n",
       "      <td>FDA NDC</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>7</th>\n",
       "      <td>DB00002</td>\n",
       "      <td>Erbitux</td>\n",
       "      <td>ImClone LLC</td>\n",
       "      <td>66733-958</td>\n",
       "      <td>Solution</td>\n",
       "      <td>Intravenous</td>\n",
       "      <td>2 mg/1mL</td>\n",
       "      <td>US</td>\n",
       "      <td>FDA NDC</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>8</th>\n",
       "      <td>DB00002</td>\n",
       "      <td>Erbitux</td>\n",
       "      <td>Imclone, Llc</td>\n",
       "      <td></td>\n",
       "      <td>Solution</td>\n",
       "      <td>Intravenous</td>\n",
       "      <td>2 mg / mL</td>\n",
       "      <td>Canada</td>\n",
       "      <td>DPD</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>9</th>\n",
       "      <td>DB00002</td>\n",
       "      <td>Erbitux</td>\n",
       "      <td>Merck Europe B.V.</td>\n",
       "      <td></td>\n",
       "      <td>Injection, solution</td>\n",
       "      <td>Intravenous</td>\n",
       "      <td>5 mg/ml</td>\n",
       "      <td>EU</td>\n",
       "      <td>EMA</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "</div>"
      ],
      "text/plain": [
       "  drugbank_id product_name                labeller ndc_product_code  \\\n",
       "0     DB00001     Refludan                   Bayer        50419-150   \n",
       "1     DB00001     Refludan                   Bayer                    \n",
       "2     DB00001     Refludan  Celgene Europe Limited                    \n",
       "3     DB00001     Refludan  Celgene Europe Limited                    \n",
       "4     DB00001     Refludan  Celgene Europe Limited                    \n",
       "5     DB00001     Refludan  Celgene Europe Limited                    \n",
       "6     DB00002      Erbitux             ImClone LLC        66733-948   \n",
       "7     DB00002      Erbitux             ImClone LLC        66733-958   \n",
       "8     DB00002      Erbitux            Imclone, Llc                    \n",
       "9     DB00002      Erbitux       Merck Europe B.V.                    \n",
       "\n",
       "                        dosage_form        route      strength country  \\\n",
       "0                            Powder  Intravenous     50 mg/1mL      US   \n",
       "1              Powder, for solution  Intravenous  50 mg / vial  Canada   \n",
       "2  Injection, solution, concentrate  Intravenous         50 mg      EU   \n",
       "3  Injection, solution, concentrate  Intravenous         50 mg      EU   \n",
       "4  Injection, solution, concentrate  Intravenous         20 mg      EU   \n",
       "5  Injection, solution, concentrate  Intravenous         20 mg      EU   \n",
       "6                          Solution  Intravenous      2 mg/1mL      US   \n",
       "7                          Solution  Intravenous      2 mg/1mL      US   \n",
       "8                          Solution  Intravenous     2 mg / mL  Canada   \n",
       "9               Injection, solution  Intravenous       5 mg/ml      EU   \n",
       "\n",
       "    source  \n",
       "0  FDA NDC  \n",
       "1      DPD  \n",
       "2      EMA  \n",
       "3      EMA  \n",
       "4      EMA  \n",
       "5      EMA  \n",
       "6  FDA NDC  \n",
       "7  FDA NDC  \n",
       "8      DPD  \n",
       "9      EMA  "
      ]
     },
     "execution_count": 5,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "from transformations import build_products_dataframe\n",
    "\n",
    "df_products = build_products_dataframe(XML_PATH)\n",
    "df_products.head(10)"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "# Task #4"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 6,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>drugbank_id</th>\n",
       "      <th>pathway_name</th>\n",
       "      <th>smpdb-id</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>DB00001</td>\n",
       "      <td>Lepirudin Action Pathway</td>\n",
       "      <td>SMP0000278</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1</th>\n",
       "      <td>DB00002</td>\n",
       "      <td>Cetuximab Action Pathway</td>\n",
       "      <td>SMP0000474</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2</th>\n",
       "      <td>DB00006</td>\n",
       "      <td>Bivalirudin Action Pathway</td>\n",
       "      <td>SMP0000277</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3</th>\n",
       "      <td>DB00009</td>\n",
       "      <td>Alteplase Action Pathway</td>\n",
       "      <td>SMP0000280</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>4</th>\n",
       "      <td>DB00013</td>\n",
       "      <td>Urokinase Action Pathway</td>\n",
       "      <td>SMP0000284</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>5</th>\n",
       "      <td>DB00015</td>\n",
       "      <td>Reteplase Action Pathway</td>\n",
       "      <td>SMP0000285</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>6</th>\n",
       "      <td>DB00029</td>\n",
       "      <td>Anistreplase Action Pathway</td>\n",
       "      <td>SMP0000281</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>7</th>\n",
       "      <td>DB00031</td>\n",
       "      <td>Tenecteplase Action Pathway</td>\n",
       "      <td>SMP0000283</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>8</th>\n",
       "      <td>DB00054</td>\n",
       "      <td>Abciximab Action Pathway</td>\n",
       "      <td>SMP0000265</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>9</th>\n",
       "      <td>DB00063</td>\n",
       "      <td>Eptifibatide Action Pathway</td>\n",
       "      <td>SMP0000266</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "</div>"
      ],
      "text/plain": [
       "  drugbank_id                 pathway_name    smpdb-id\n",
       "0     DB00001     Lepirudin Action Pathway  SMP0000278\n",
       "1     DB00002     Cetuximab Action Pathway  SMP0000474\n",
       "2     DB00006   Bivalirudin Action Pathway  SMP0000277\n",
       "3     DB00009     Alteplase Action Pathway  SMP0000280\n",
       "4     DB00013     Urokinase Action Pathway  SMP0000284\n",
       "5     DB00015     Reteplase Action Pathway  SMP0000285\n",
       "6     DB00029  Anistreplase Action Pathway  SMP0000281\n",
       "7     DB00031  Tenecteplase Action Pathway  SMP0000283\n",
       "8     DB00054     Abciximab Action Pathway  SMP0000265\n",
       "9     DB00063  Eptifibatide Action Pathway  SMP0000266"
      ]
     },
     "execution_count": 6,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "from transformations import build_pathways_dataframe\n",
    "\n",
    "df_pathways = build_pathways_dataframe(XML_PATH)\n",
    "df_pathways.head(10)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 7,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "12"
      ]
     },
     "execution_count": 7,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "from analyses import count_unique_pathways\n",
    "\n",
    "count_unique_pathways(df_pathways)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 8,
   "metadata": {},
   "outputs": [],
   "source": [
    "# TODO: recheck if this task is done correctly as it influences 5 and 6 as well. What does it mean for a pathway to interact with a drug?"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "# Task #5"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "metadata": {},
   "outputs": [],
   "source": []
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "# Task #6"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "metadata": {},
   "outputs": [],
   "source": []
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "# Task #7"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>drugbank_id</th>\n",
       "      <th>target_id</th>\n",
       "      <th>external_id</th>\n",
       "      <th>external_source</th>\n",
       "      <th>polypeptide_name</th>\n",
       "      <th>polypeptide_gene_name</th>\n",
       "      <th>polypeptide_chromosome_location</th>\n",
       "      <th>polypeptide_cellular_location</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>DB00001</td>\n",
       "      <td>BE0000048</td>\n",
       "      <td>P00734</td>\n",
       "      <td>Swiss-Prot</td>\n",
       "      <td>Prothrombin</td>\n",
       "      <td>F2</td>\n",
       "      <td>11</td>\n",
       "      <td>Secreted</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1</th>\n",
       "      <td>DB00002</td>\n",
       "      <td>BE0000767</td>\n",
       "      <td>P00533</td>\n",
       "      <td>Swiss-Prot</td>\n",
       "      <td>Epidermal growth factor receptor</td>\n",
       "      <td>EGFR</td>\n",
       "      <td>7</td>\n",
       "      <td>Cell membrane</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2</th>\n",
       "      <td>DB00002</td>\n",
       "      <td>BE0000901</td>\n",
       "      <td>O75015</td>\n",
       "      <td>Swiss-Prot</td>\n",
       "      <td>Low affinity immunoglobulin gamma Fc region re...</td>\n",
       "      <td>FCGR3B</td>\n",
       "      <td>1</td>\n",
       "      <td>Cell membrane</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3</th>\n",
       "      <td>DB00002</td>\n",
       "      <td>BE0002094</td>\n",
       "      <td>P02745</td>\n",
       "      <td>Swiss-Prot</td>\n",
       "      <td>Complement C1q subcomponent subunit A</td>\n",
       "      <td>C1QA</td>\n",
       "      <td>1</td>\n",
       "      <td>Secreted</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>4</th>\n",
       "      <td>DB00002</td>\n",
       "      <td>BE0002095</td>\n",
       "      <td>P02746</td>\n",
       "      <td>Swiss-Prot</td>\n",
       "      <td>Complement C1q subcomponent subunit B</td>\n",
       "      <td>C1QB</td>\n",
       "      <td>1</td>\n",
       "      <td>Secreted</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>5</th>\n",
       "      <td>DB00002</td>\n",
       "      <td>BE0002096</td>\n",
       "      <td>P02747</td>\n",
       "      <td>Swiss-Prot</td>\n",
       "      <td>Complement C1q subcomponent subunit C</td>\n",
       "      <td>C1QC</td>\n",
       "      <td>1</td>\n",
       "      <td>Secreted</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>6</th>\n",
       "      <td>DB00002</td>\n",
       "      <td>BE0002097</td>\n",
       "      <td>P08637</td>\n",
       "      <td>Swiss-Prot</td>\n",
       "      <td>Low affinity immunoglobulin gamma Fc region re...</td>\n",
       "      <td>FCGR3A</td>\n",
       "      <td>1</td>\n",
       "      <td>Cell membrane</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>7</th>\n",
       "      <td>DB00002</td>\n",
       "      <td>BE0000710</td>\n",
       "      <td>P12314</td>\n",
       "      <td>Swiss-Prot</td>\n",
       "      <td>High affinity immunoglobulin gamma Fc receptor I</td>\n",
       "      <td>FCGR1A</td>\n",
       "      <td>1</td>\n",
       "      <td>Cell membrane</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>8</th>\n",
       "      <td>DB00002</td>\n",
       "      <td>BE0002098</td>\n",
       "      <td>P12318</td>\n",
       "      <td>Swiss-Prot</td>\n",
       "      <td>Low affinity immunoglobulin gamma Fc region re...</td>\n",
       "      <td>FCGR2A</td>\n",
       "      <td>1</td>\n",
       "      <td>Cell membrane</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>9</th>\n",
       "      <td>DB00004</td>\n",
       "      <td>BE0000658</td>\n",
       "      <td>P01589</td>\n",
       "      <td>Swiss-Prot</td>\n",
       "      <td>Interleukin-2 receptor subunit alpha</td>\n",
       "      <td>IL2RA</td>\n",
       "      <td>10</td>\n",
       "      <td>Membrane</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "</div>"
      ],
      "text/plain": [
       "  drugbank_id  target_id external_id external_source  \\\n",
       "0     DB00001  BE0000048      P00734      Swiss-Prot   \n",
       "1     DB00002  BE0000767      P00533      Swiss-Prot   \n",
       "2     DB00002  BE0000901      O75015      Swiss-Prot   \n",
       "3     DB00002  BE0002094      P02745      Swiss-Prot   \n",
       "4     DB00002  BE0002095      P02746      Swiss-Prot   \n",
       "5     DB00002  BE0002096      P02747      Swiss-Prot   \n",
       "6     DB00002  BE0002097      P08637      Swiss-Prot   \n",
       "7     DB00002  BE0000710      P12314      Swiss-Prot   \n",
       "8     DB00002  BE0002098      P12318      Swiss-Prot   \n",
       "9     DB00004  BE0000658      P01589      Swiss-Prot   \n",
       "\n",
       "                                    polypeptide_name polypeptide_gene_name  \\\n",
       "0                                        Prothrombin                    F2   \n",
       "1                   Epidermal growth factor receptor                  EGFR   \n",
       "2  Low affinity immunoglobulin gamma Fc region re...                FCGR3B   \n",
       "3              Complement C1q subcomponent subunit A                  C1QA   \n",
       "4              Complement C1q subcomponent subunit B                  C1QB   \n",
       "5              Complement C1q subcomponent subunit C                  C1QC   \n",
       "6  Low affinity immunoglobulin gamma Fc region re...                FCGR3A   \n",
       "7   High affinity immunoglobulin gamma Fc receptor I                FCGR1A   \n",
       "8  Low affinity immunoglobulin gamma Fc region re...                FCGR2A   \n",
       "9               Interleukin-2 receptor subunit alpha                 IL2RA   \n",
       "\n",
       "  polypeptide_chromosome_location polypeptide_cellular_location  \n",
       "0                              11                      Secreted  \n",
       "1                               7                 Cell membrane  \n",
       "2                               1                 Cell membrane  \n",
       "3                               1                      Secreted  \n",
       "4                               1                      Secreted  \n",
       "5                               1                      Secreted  \n",
       "6                               1                 Cell membrane  \n",
       "7                               1                 Cell membrane  \n",
       "8                               1                 Cell membrane  \n",
       "9                              10                      Membrane  "
      ]
     },
     "execution_count": 9,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "from transformations import build_targets_dataframe\n",
    "\n",
    "targets_df = build_targets_dataframe(XML_PATH)\n",
    "targets_df.head(10)"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "# Task #8"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "metadata": {},
   "outputs": [],
   "source": [
    "from visualizations import draw_pie_cellular_locations\n",
    "\n",
    "draw_pie_cellular_locations()"
   ]
  }
 ],
 "metadata": {
  "kernelspec": {
   "display_name": "Python 3",
   "language": "python",
   "name": "python3"
  },
  "language_info": {
   "codemirror_mode": {
    "name": "ipython",
    "version": 3
   },
   "file_extension": ".py",
   "mimetype": "text/x-python",
   "name": "python",
   "nbconvert_exporter": "python",
   "pygments_lexer": "ipython3",
   "version": "3.10.12"
  }
 },
 "nbformat": 4,
 "nbformat_minor": 2
}
